CLS
Celestica Inc.
CLS has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CLS overall, supported by stronger fundamentals and stronger valuation.
CLS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
CLS's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $115 | -55% |
| Forward | 14x | $254 | — |
| Fair | 17x | $184 | -28% |
| Current | 24x | $254 | — |
| Expensive | 39x | $411 | +62% |
Historical ranges are pointers, not guarantees.
CLS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over CLS in the historical PE scenario, which offers more potential upside but is not a forecast.
CLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for CLS, with profitability holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over CLS on the outlook, with more favorable profitability expectations.
CLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $17.88 | +70% |
| Q3 2026 | $10.55 | +75% |
| Q2 2026 | $9.60 | +114% |
| Q1 2026 | $8.25 | +138% |
| Q4 2025 | $7.16 | +105% |
| Q3 2025 | $6.03 | +98% |
| Q2 2025 | $4.49 | +53% |
| Q1 2025 | $3.47 | +33% |
| Q4 2024 | $3.50 | +72% |
CLS's earnings per share have climbed steadily: $10.55 over the past year, up 75% from the year before, and higher year over year for 23 quarters in a row.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CLS in the latest year-over-year earnings comparison.
CLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.8B | +83% |
| Q2 2026 | $4.7B | +62% |
| Q1 2026 | $4B | +53% |
| Q4 2025 | $3.7B | +44% |
| Q3 2025 | $3.2B | +28% |
| Q2 2025 | $2.9B | +21% |
| Q1 2025 | $2.6B | +20% |
| Q4 2024 | $2.5B | +19% |
CLS's revenue has grown year over year for 20 quarters in a row: $5.8B last quarter, up 83% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -2.3 points |
| Q2 2026 | 9.8% | +0.3 points |
| Q1 2026 | 6.7% | +1.9 points |
| Q4 2025 | 8.6% | +0.9 points |
| Q3 2025 | 10% | +4.7 points |
| Q2 2025 | 9.4% | +3.9 points |
| Q1 2025 | 4.9% | -0.8 points |
| Q4 2024 | 7.7% | +2.1 points |
CLS's operating margin was 7.9% last quarter, down 2.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CLS on profitability, with a higher operating margin.
CLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $115.6M | +30% |
| Q2 2026 | $147.1M | +23% |
| Q1 2026 | $126.8M | +35% |
| Q4 2025 | $155.9M | +471% |
| Q3 2025 | $88.9M | -10% |
| Q2 2025 | $119.9M | +91% |
| Q1 2025 | $93.6M | +38% |
| Q4 2024 | $27.3M | -74% |
CLS has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +5.6M shares |
| 1 year | +5.1% | +5.9M shares |
| 3 years | +1.8% | +2.2M shares |
| 5 years | -2.9% | -3.7M shares |
| Available history | -5.2% | -6.7M shares |
CLS has 122M diluted shares, up 5.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $22.6M |
| Q4 2025 | $35.7M |
| Q3 2025 | — |
| Q2 2025 | $40M |
| Q1 2025 | $77.7M |
| Q4 2024 | $25.5M |
CLS spent $58M buying back its own shares over the past year, down 59% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over CLS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 0.5x | Very low |
CLS has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.2 | Neutral |
| Stochastic | 15.5 | Oversold |
CLS's weekly RSI is 42 (neutral) and its Stochastic is 16 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CLS PE vs Technology Sector
| Metric | CLS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 14% below |
| PE % | 64 | 35 | 29 pts above |
CLS is trading at 24x earnings, a 14% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over CLS on valuation relative to its sector.
CLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $300.6 | 15% below |
| 20 week MA | $313.9 | 19% below |
| 50 week MA | $321.3 | 21% below |
| 100 week MA | $243.1 | 4.5% above |
| 200 week MA | $139.6 | 82% above |
CLS has stronger trend alignment. CLS is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $7.71 | -4.9% |
| 2021 | $7.71 | $10.9 | +41% |
| 2022 | $10.9 | $10.9 | -0.2% |
| 2023 | $10.9 | $29.3 | +170% |
| 2024 | $29.3 | $95.1 | +225% |
| 2025 | $95.1 | $303.6 | +219% |
| 2026 YTD | $303.6 | $254.0 | -16% |
CLS has finished higher in four of the last six years, three of them by more than 50%. It's down 16% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CLS on returns for 2026, with the stronger performance.